Fundraising Fox

Nuevocor

Singapore, SG · Founded 2021 · 29 employees on LinkedIn · 6 known investors

Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases. The company leverages innovative cell biology and gene therapy technologies to address genetic and acquired cardiac conditions.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

Nuevocor was founded in 2021 by Brian Burke, Mark Kay, Colin Stewart, and Yann Chong Tan.

BBBrian Burke
Brian BurkeinCo-Founder and Advisor
MK
Mark KayCo-Founder and Advisor
CS
Colin StewartCo-Founder and Advisor
YCYann Chong Tan
Yann Chong TaninCo-Founder and Advisor
MSMonica Shah
Monica ShahinChief Medical Officer
AG
Al GianchettiinChief Executive Officer

Investors · 6

Angelini Ventures✓ verifiedRome
Kurma Partners✓ verifiedParis · $162K – $10.8M
Boehringer Ingelheim Venture Fund✓ verifiedIngelheim am Rhein · $16.2M
ClavystBioSingapore
Highlight CapitalreportedNanjin · $2.8M – $74M
SEEDS CapitalreportedSingapore · $250K – $9M

Funding

SEC filings, press & company announcements

$45M disclosed across 1 of 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Nuevocor Raises $45 Million in Series B Funding Round | Precision Medicine Onlineprecisionmedicineonline.com · May 2025Fort Washington’s Nuevocor Raises $45M to Advance Gene Therapy for Heart Failuremontco.today · May 2025Singapore-based biotech firm Nuevocor raises US$45 million in Series B round - The Business Timesbusinesstimes.com.sg · May 2025Nuevocor Closes US$45M Series B Financingfinsmes.com · May 2025Nuevocor Closes US$45 Million Series B Financing for Clinical Development of Novel Mechanobiology-Centered Therapy for Cardiomyopathyprnewswire.com · May 2025FDA Clears Nuevocor’s IND for NVC-001 Gene Therapy Targeting LMNA-Related Dilated Cardiomyopathylmnacardiac.org

Frequently asked questions

What does Nuevocor do?
Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases. The company leverages innovative cell biology and gene therapy technologies to address genetic and acquired cardiac conditions.
Who founded Nuevocor?
Nuevocor was founded by Brian Burke, Mark Kay, Colin Stewart, Yann Chong Tan in 2021.
Who are Nuevocor's investors?
Nuevocor's investors include Angelini Ventures, Kurma Partners, Boehringer Ingelheim Venture Fund, ClavystBio, Highlight Capital, SEEDS Capital.
How much funding has Nuevocor raised?
Nuevocor has disclosed $45M raised across 1 of its 2 known rounds.
Where is Nuevocor headquartered?
Nuevocor is headquartered in Singapore, SG.